Selected Mediators of Inflammation in Patients with Acute Ischemic Stroke
During a stroke, a series of biochemical and metabolic changes occur which eventually lead to the death of cells by necrosis or apoptosis. This is a multi-stage process involving oxidative stress and an inflammatory response from the first signs of occlusion of a blood vessel until the late stages o...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-09-01
|
| Series: | International Journal of Molecular Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1422-0067/23/18/10614 |
| _version_ | 1797487247976562688 |
|---|---|
| author | Hanna Pawluk Renata Kołodziejska Grzegorz Grześk Mariusz Kozakiewicz Alina Woźniak Mateusz Pawluk Agnieszka Kosinska Magdalena Grześk Jakub Wojtasik Grzegorz Kozera |
| author_facet | Hanna Pawluk Renata Kołodziejska Grzegorz Grześk Mariusz Kozakiewicz Alina Woźniak Mateusz Pawluk Agnieszka Kosinska Magdalena Grześk Jakub Wojtasik Grzegorz Kozera |
| author_sort | Hanna Pawluk |
| collection | DOAJ |
| description | During a stroke, a series of biochemical and metabolic changes occur which eventually lead to the death of cells by necrosis or apoptosis. This is a multi-stage process involving oxidative stress and an inflammatory response from the first signs of occlusion of a blood vessel until the late stages of regeneration and healing of ischemic tissues. The purpose of the research was to assess the concentration of pro-inflammatory cytokines IL-6 and TNF-α in the blood serum of patients with ischemic stroke (AIS) and to investigate their role as new markers in predicting functional prognosis after thrombolytic therapy. The researches have shown that the concentrations of the measured biomarkers were higher compared to the control group. Serum levels of IL-6 and THF-α before the initiation of intravenous thrombolysis were lower in the subgroup of patients with a favourable functional result (mRS: 0–2 pts) compared to the group of patients with an unfavourable functional result (mRS: 3–6 pts). A positive correlation was found between the concentration of IL-6 and TNF-α in patients with AIS during <4.5 h and on one day after the onset of stroke, which means that the concentration of IL-6 increases with the increase in TNF-α concentration. It has also been shown that higher levels of IL-6 in the acute phase of stroke and on the first and seventh days, and TNF-α during onset, were associated with poorer early and late prognosis in patients treated with intravenous thrombolysis. A relationship was found between the level of IL-6 and TNF-α in the subacute AIS and the severity of the neurological deficit. It has been shown that the investigated biomarkers may be a prognostic factor in the treatment of thrombolytic AIS. |
| first_indexed | 2024-03-09T23:44:56Z |
| format | Article |
| id | doaj.art-990ec9d320e04f60b43bfc39ed9a35b8 |
| institution | Directory Open Access Journal |
| issn | 1661-6596 1422-0067 |
| language | English |
| last_indexed | 2024-03-09T23:44:56Z |
| publishDate | 2022-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | International Journal of Molecular Sciences |
| spelling | doaj.art-990ec9d320e04f60b43bfc39ed9a35b82023-11-23T16:44:56ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-09-0123181061410.3390/ijms231810614Selected Mediators of Inflammation in Patients with Acute Ischemic StrokeHanna Pawluk0Renata Kołodziejska1Grzegorz Grześk2Mariusz Kozakiewicz3Alina Woźniak4Mateusz Pawluk5Agnieszka Kosinska6Magdalena Grześk7Jakub Wojtasik8Grzegorz Kozera9Department of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karłowicza 24, 85–092 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karłowicza 24, 85–092 Bydgoszcz, PolandDepartment of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Ujejskiego 75, 85-168 Bydgoszcz, PolandDivision of Biochemistry and Biogerontology, Department of Geriatrics, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Dębowa 3, 85-626 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karłowicza 24, 85–092 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karłowicza 24, 85–092 Bydgoszcz, PolandCentre for Languages & International Education, University College London, 26 Bedford Way, London WC1H 0AP, UKDepartment of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Ujejskiego 75, 85-168 Bydgoszcz, PolandStatistical Analysis Centre, Nicolaus Copernicus University in Toruń, Chopin 12/18, 87-100 Toruń, PolandMedical Stimulation Centre, Medical University of Gdańsk, Dębowa 25, 80-204 Gdańsk, PolandDuring a stroke, a series of biochemical and metabolic changes occur which eventually lead to the death of cells by necrosis or apoptosis. This is a multi-stage process involving oxidative stress and an inflammatory response from the first signs of occlusion of a blood vessel until the late stages of regeneration and healing of ischemic tissues. The purpose of the research was to assess the concentration of pro-inflammatory cytokines IL-6 and TNF-α in the blood serum of patients with ischemic stroke (AIS) and to investigate their role as new markers in predicting functional prognosis after thrombolytic therapy. The researches have shown that the concentrations of the measured biomarkers were higher compared to the control group. Serum levels of IL-6 and THF-α before the initiation of intravenous thrombolysis were lower in the subgroup of patients with a favourable functional result (mRS: 0–2 pts) compared to the group of patients with an unfavourable functional result (mRS: 3–6 pts). A positive correlation was found between the concentration of IL-6 and TNF-α in patients with AIS during <4.5 h and on one day after the onset of stroke, which means that the concentration of IL-6 increases with the increase in TNF-α concentration. It has also been shown that higher levels of IL-6 in the acute phase of stroke and on the first and seventh days, and TNF-α during onset, were associated with poorer early and late prognosis in patients treated with intravenous thrombolysis. A relationship was found between the level of IL-6 and TNF-α in the subacute AIS and the severity of the neurological deficit. It has been shown that the investigated biomarkers may be a prognostic factor in the treatment of thrombolytic AIS.https://www.mdpi.com/1422-0067/23/18/10614ischemic strokeinterleukin-6tumor necrosis factormodified Rankin ScaleNational Institutes of Health Stroke Scale |
| spellingShingle | Hanna Pawluk Renata Kołodziejska Grzegorz Grześk Mariusz Kozakiewicz Alina Woźniak Mateusz Pawluk Agnieszka Kosinska Magdalena Grześk Jakub Wojtasik Grzegorz Kozera Selected Mediators of Inflammation in Patients with Acute Ischemic Stroke International Journal of Molecular Sciences ischemic stroke interleukin-6 tumor necrosis factor modified Rankin Scale National Institutes of Health Stroke Scale |
| title | Selected Mediators of Inflammation in Patients with Acute Ischemic Stroke |
| title_full | Selected Mediators of Inflammation in Patients with Acute Ischemic Stroke |
| title_fullStr | Selected Mediators of Inflammation in Patients with Acute Ischemic Stroke |
| title_full_unstemmed | Selected Mediators of Inflammation in Patients with Acute Ischemic Stroke |
| title_short | Selected Mediators of Inflammation in Patients with Acute Ischemic Stroke |
| title_sort | selected mediators of inflammation in patients with acute ischemic stroke |
| topic | ischemic stroke interleukin-6 tumor necrosis factor modified Rankin Scale National Institutes of Health Stroke Scale |
| url | https://www.mdpi.com/1422-0067/23/18/10614 |
| work_keys_str_mv | AT hannapawluk selectedmediatorsofinflammationinpatientswithacuteischemicstroke AT renatakołodziejska selectedmediatorsofinflammationinpatientswithacuteischemicstroke AT grzegorzgrzesk selectedmediatorsofinflammationinpatientswithacuteischemicstroke AT mariuszkozakiewicz selectedmediatorsofinflammationinpatientswithacuteischemicstroke AT alinawozniak selectedmediatorsofinflammationinpatientswithacuteischemicstroke AT mateuszpawluk selectedmediatorsofinflammationinpatientswithacuteischemicstroke AT agnieszkakosinska selectedmediatorsofinflammationinpatientswithacuteischemicstroke AT magdalenagrzesk selectedmediatorsofinflammationinpatientswithacuteischemicstroke AT jakubwojtasik selectedmediatorsofinflammationinpatientswithacuteischemicstroke AT grzegorzkozera selectedmediatorsofinflammationinpatientswithacuteischemicstroke |